Methods of diagnosing or monitoring an autoimmune or chronic inflammatory
disease, particularly SLE in a patient by detecting the expression level of one
or more genes or surrogates derived therefrom in the patient are described. Diagnostic
oligonucleotides for diagnosing or monitoring chronic inflammatory disease, particularly
SLE infection and kits or systems containing the same are also described.
